Telomir Pharmaceuticals, Inc.
TELO
$4.58
-$0.45-8.95%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 105,408.33% | 33,284.00% | 12,803.42% | 233,778.57% | -14.29% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 8,171.43% | 7,630.00% | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -44.18% | -- | -- | 816.07% |
Total Current Assets | 204.23% | 340.96% | 2,086.99% | -- | 793.63% |
|
|||||
Total Current Assets | 204.23% | 340.96% | 2,086.99% | -- | 793.63% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -72.27% | -80.41% | -64.51% | -- | 9,702.46% |
|
|||||
Total Accounts Payable | -16.93% | 2.12% | -53.43% | -- | 74.96% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -85.14% | -96.45% | -71.27% | -- | 8.01% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -49.01% | -80.90% | -73.72% | -- | 35.46% |
|
|||||
Total Current Liabilities | -49.01% | -80.90% | -73.72% | -- | 35.46% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -85.14% | -96.45% | -71.27% | -- | 8.01% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -49.01% | -80.90% | -73.72% | -- | 35.46% |
|
|||||
Common Stock & APIC | 78.49% | 306.95% | 237.46% | -- | 31,722.36% |
Retained Earnings | -117.55% | -484.74% | -619.45% | -- | -1,317.32% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -81.30% | -79.70% | -59.70% | 421.84% | 466.82% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -81.30% | -79.70% | -59.70% | 421.84% | 466.82% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -81.30% | -79.70% | -59.70% | 421.84% | 466.82% |
|